Brain State Technologies announces the presentation of results from a case series of 21 individuals with persisting symptoms following traumatic brain injury.Continue reading
Author Archive: AZBio
Senestech featured in the Wall Street Journal
Tasty Bait That Attacks Rats’ Fertility
Experimental Birth Control to Control Rodent Population (Wall Street Journal)Continue reading
TOPCAT Trial Tests Possible Treatment for Patients with Heart Failure and Preserved Heart Pump Function
Nancy K. Sweitzer, MD, PhD, director of the University of Arizona Sarver Heart Center and chief of the Division of Cardiology at the UA College of Medicine – Tucson serves on the TOPCAT executive committee.Continue reading
TGen study identifies growth factor receptors that may prompt the spread of lung cancer
Preventing lung cancers from metastasizing to other parts of the body could provide benefit for patients against the leading cause of cancer deathContinue reading
Noyce Scholars: Creating Pathway for Future STEM Educators
College Seeks STEM Professionals for Teacher CertificationContinue reading
TGen Dr. Michael Barrett awarded $200,000 grant at national cancer conference in San Diego April 9th, 2014
Ulthera, Inc. Appoints Marshall L. Mohr to Board of Directors
MESA, AZ–(Marketwired – Apr 10, 2014) –Ulthera, Inc., a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications, announced today that Marshall L. Mohr has joined its board of directors.Continue reading
Patrick Roche, Ph.D., Joins HTG Molecular Diagnostics
TUCSON, Ariz. (April 9, 2014) HTG Molecular Diagnostics, Inc., (HTG) today announced that Patrick Roche, Ph.D., has joined the company as Sr. Vice President for IVD Assay Development.Continue reading
AZBio CEO Makes the Case for Medical Innovation Investments in the Arizona Capitol Times
Saving money, improving lives – investing in medical innovation is a smart budget decisionContinue reading
PhRMA Report Looks at Alternate Growth Scenarios
New Report Reveals Growth Trajectories and Top Policy Factors Affecting Biopharmaceutical Innovation & Growth. New analysis incorporates real world insights from industry leadersContinue reading